REQUEST A DEMO
Total
USD $0.00
Search more companies

Oncobiologico CIA Ltda (Ecuador)

Main Activities: Pharmacies and Drug Stores
Full name: Oncobiologico CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Oncobiologico CIA Ltda is a company based in Ecuador, with its head office in Cuenca. It operates in the Pharmacies and Drug Stores industry. It was established on February 07, 2007. Oncobiologico CIA Ltda currently employs 11 (2021) people. From the latest financial highlights, Oncobiologico CIA Ltda reported a net sales revenue drop of 14.41% in 2022. Over the same period, its total assets grew by 15.3%. The enterprise’s net profit margin decreased by 0.22% in 2022.

Headquarters
Alfonso Moreno Mora 3-65
Cuenca; Azuay;

Contact Details: Purchase the Oncobiologico CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Oncobiologico CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Oncobiologico CIA Ltda report to view the information.
Registered Capital:
Purchase the Oncobiologico CIA Ltda report to view the information.
Incorporation Date:
February 07, 2007
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
30%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Oncobiologico CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-14.41%
Total operating revenue
-14.41%
Operating profit (EBIT)
32.53%
Net Profit (Loss) for the Period
-17.56%
Total assets
15.3%
Total equity
17.73%
Operating Profit Margin (ROS)
5.51%
Net Profit Margin
-0.22%
Return on Equity (ROE)
-14.89%
Quick Ratio
-0.25%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?